At a glance
ClinicalIndex Comparison RecordN/ACompleted· 78 enrolled
Drug / intervention
Guaifenesin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
In Brief
A clinical study evaluating Guaifenesin and Placebo for Upper Back Pain. Completed, enrolled 78 participants across 5 sites.
Detailed Summary
Explore the clinical efficacy of 7-day treatment regimens of guaifenesin in order to investigate the evidence that guaifenesin is an effective treatment for upper back/neck/shoulder muscle spasm/stiffness and pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUpper Back Pain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2012
First PostedMar 2012
Primary CompletionMay 2013
TodayJul 2026
First PostedMar 26, 2012
Enrollment StartFeb 1, 2012
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 14.3 years ago
Interventions
Guaifenesindrug
high and low dose of Guaifenesin each given twice daily over a 4-day treatment period
Placebodrug
no active ingredient